TY - JOUR
T1 - Gestational trophoblastic neoplasia, version 2.2019
AU - Abu-Rustum, Nadeem R.
AU - Yashar, Catheryn M.
AU - Bean, Sarah
AU - Bradley, Kristin
AU - Campos, Susana M.
AU - Sook Chon, Hye
AU - Chu, Christina
AU - Cohn, David
AU - Crispens, Marta Ann
AU - Damast, Shari
AU - Dorigo, Oliver
AU - Eifel, Patricia J.
AU - Fisher, Christine M.
AU - Frederick, Peter
AU - Gaffney, David K.
AU - Han, Ernest
AU - Huh, Warner K.
AU - Lurain, John R.
AU - Mariani, Andrea
AU - Mutch, David
AU - Nagel, Christa
AU - Nekhlyudov, Larissa
AU - NicklesFader, Amanda
AU - Remmenga, Steven W.
AU - KevinReynolds, R. R.
AU - Sisodia, Rachel
AU - Tillmanns, Todd
AU - Ueda, Stefanie
AU - Wyse, Emily
AU - McMillian, Nicole R.
AU - Scavone, Jillian
N1 - Publisher Copyright:
© 2019. All rights reserved.
PY - 2019
Y1 - 2019
N2 - Gestational trophoblastic neoplasia (GTN), a subset of gestational trophoblastic disease (GTD), occurs when tumors develop in the cells that would normally form the placenta during pregnancy. The NCCN Guidelines for Gestational Trophoblastic Neoplasia provides treatment recommendations for various types of GTD including hydatidiform mole, persistent post-molar GTN, low-risk GTN, highrisk GTN, and intermediate trophoblastic tumor.
AB - Gestational trophoblastic neoplasia (GTN), a subset of gestational trophoblastic disease (GTD), occurs when tumors develop in the cells that would normally form the placenta during pregnancy. The NCCN Guidelines for Gestational Trophoblastic Neoplasia provides treatment recommendations for various types of GTD including hydatidiform mole, persistent post-molar GTN, low-risk GTN, highrisk GTN, and intermediate trophoblastic tumor.
UR - http://www.scopus.com/inward/record.url?scp=85074621737&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2019.0053
DO - 10.6004/jnccn.2019.0053
M3 - Review article
C2 - 31693991
AN - SCOPUS:85074621737
SN - 1540-1405
VL - 17
SP - 1374
EP - 1391
JO - JNCCN Journal of the National Comprehensive Cancer Network
JF - JNCCN Journal of the National Comprehensive Cancer Network
IS - 11
ER -